IARTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
INTEGRA LIFESCIENCES HOLDINGS CORP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$13.45+0.24 (+1.82%)
Close on Oct 19, 2026
- Market cap
- $1.05B
- P/E (TTM)
- –
- Dividend yield
- –
Integra Lifesciences statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | Integra Lifesciences | Industry median |
|---|---|---|
| Market Cap | $1.05B | $229.23M |
| Enterprise Value | $771.96M | $194.73M |
| PS Ratio | 0.63 | 3.14 |
| PB Ratio | 1.00 | 3.19 |
| P/FCF Ratio | 40.54 | 27.25 |
| P/OCF Ratio | 12.26 | 22.23 |
Enterprise value
| Measure | Integra Lifesciences | Industry median |
|---|---|---|
| EV / Sales | 0.47 | 2.93 |
| EV / EBITDA | 11.78 | 19.97 |
| EV / EBIT | 11.78 | 25.47 |
| EV / FCF | 29.92 | 27.85 |
Income (trailing twelve months)
| Measure | Integra Lifesciences | Industry median |
|---|---|---|
| Revenue | $1.65B | $102.39M |
| Gross Profit | $864.58M | $60.36M |
| Operating Income | $65.56M | -$4.31M |
| Pretax Income | -$179.00K | -$2.26M |
| Net Income | -$7.24M | -$6.57M |
| EBITDA | $65.56M | -$1.98M |
| EPS (Diluted) | -$0.09 | -$0.07 |
Margins
| Measure | Integra Lifesciences | Industry median |
|---|---|---|
| Gross Margin | 52.5% | 55.1% |
| Operating Margin | 3.98% | -6.04% |
| Pretax Margin | -0.01% | -4.11% |
| Profit Margin | -0.44% | -10.5% |
| EBITDA Margin | 3.98% | -2.67% |
| FCF Margin | 1.57% | -0.30% |
Returns
| Measure | Integra Lifesciences | Industry median |
|---|---|---|
| Return on Equity (ROE) | -0.70% | -19.2% |
| Return on Assets (ROA) | -0.20% | -13.3% |
| Return on Invested Capital (ROIC) | 6.66% | -4.11% |
| Return on Capital Employed (ROCE) | 2.03% | -9.07% |
Growth
| Measure | Integra Lifesciences | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 1.60% | 8.85% |
| Revenue Growth (3Y CAGR) | 1.63% | 7.08% |
| Revenue Growth (5Y CAGR) | 3.57% | 11.8% |
Balance sheet
| Measure | Integra Lifesciences | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $274.08M | $37.33M |
| Net Cash (Debt) | $274.08M | $3.92M |
| Net Cash Per Share | $3.52 | $0.28 |
| Equity (Book Value) | $1.04B | $57.36M |
| Book Value Per Share | $13.42 | $2.81 |
| Tangible Book Value | -$643.31M | $10.71M |
| Working Capital | $860.60M | $54.64M |
Financial position
| Measure | Integra Lifesciences | Industry median |
|---|---|---|
| Current Ratio | 3.60 | 2.50 |
| Quick Ratio | 1.64 | 1.54 |
| Interest Coverage | 0.71 | -1.81 |
Cash flow (trailing twelve months)
| Measure | Integra Lifesciences | Industry median |
|---|---|---|
| Operating Cash Flow | $85.33M | -$653.46K |
| Capital Expenditures | -$59.53M | -$3.69M |
| Free Cash Flow | $25.80M | -$835.02K |
| FCF Per Share | $0.33 | -$0.02 |
Efficiency
| Measure | Integra Lifesciences | Industry median |
|---|---|---|
| Asset Turnover | 0.46 | 0.59 |
| Inventory Turnover | 1.64 | 2.21 |
| Revenue Per Employee | $445.32K | $322.75K |
| Profits Per Employee | -$1.96K | -$52.11K |
| Employee Count | 3,700 | 197 |
Dividends and yields
| Measure | Integra Lifesciences | Industry median |
|---|---|---|
| Earnings Yield | -0.69% | -6.92% |
| FCF Yield | 2.47% | -0.62% |
Shares
| Measure | Integra Lifesciences | Industry median |
|---|---|---|
| Shares Outstanding | 77,772,500 | 44,856,700 |
| Shares Change (YoY) | 0.85% | 3.35% |
| Float | 75,128,000 | 36,934,400 |
| Shares Held by Insiders | 3.40% | 10.6% |
| Shares Held by Institutions | 94.4% | 63.5% |
Taxes
| Measure | Integra Lifesciences | Industry median |
|---|---|---|
| Income Tax | $7.06M | $1.52M |
Scores
| Measure | Integra Lifesciences | Industry median |
|---|---|---|
| Altman Z-Score | 1.23 | 1.95 |
| Piotroski F-Score | 5 | 5 |
Calculated by StockData from Integra Lifesciences's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.